Brokerages Set Molina Healthcare, Inc. (MOH) Price Target at $141.15
Molina Healthcare, Inc. (NYSE:MOH) has been given a consensus recommendation of “Buy” by the seventeen ratings firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $141.15.
A number of analysts recently issued reports on the company. Stephens assumed coverage on Molina Healthcare in a report on Monday, January 14th. They set an “equal weight” rating and a $144.00 price objective on the stock. Mitsubishi UFJ Financial Group raised Molina Healthcare from a “neutral” rating to an “overweight” rating in a report on Tuesday, January 8th. JPMorgan Chase & Co. raised Molina Healthcare from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $127.00 to $150.00 in a report on Tuesday, January 8th. Wolfe Research cut Molina Healthcare from an “outperform” rating to a “market perform” rating in a report on Thursday, January 3rd. Finally, ValuEngine raised Molina Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, January 2nd.
MOH traded down $0.80 during trading on Wednesday, reaching $136.10. 6,708 shares of the company were exchanged, compared to its average volume of 543,573. The stock has a market capitalization of $8.54 billion, a price-to-earnings ratio of 244.43, a price-to-earnings-growth ratio of 1.18 and a beta of 1.67. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.40 and a current ratio of 1.40. Molina Healthcare has a 12-month low of $71.07 and a 12-month high of $154.06.
Institutional investors have recently made changes to their positions in the company. Financial Gravity Companies Inc. bought a new position in shares of Molina Healthcare during the 4th quarter valued at about $51,000. Cypress Capital Management LLC WY increased its position in shares of Molina Healthcare by 82.4% during the 4th quarter. Cypress Capital Management LLC WY now owns 602 shares of the company’s stock valued at $70,000 after purchasing an additional 272 shares during the last quarter. MERIAN GLOBAL INVESTORS UK Ltd bought a new position in shares of Molina Healthcare during the 4th quarter valued at about $139,000. DekaBank Deutsche Girozentrale increased its position in shares of Molina Healthcare by 185.1% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 1,226 shares of the company’s stock valued at $170,000 after purchasing an additional 796 shares during the last quarter. Finally, Ibex Investors LLC bought a new position in shares of Molina Healthcare during the 3rd quarter valued at about $200,000.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Featured Article: How to Use the New Google Finance Tool
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.